Skip to content

the evaluation of Clonidine versus Ondansetron for control of pain, nausea & vomiting after Orthognathic surgery.

The evaluation of pre-operative Clonidine versus Ondansetron prescription for control of pain, nausea & vomiting after Orthognathic surgery.

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT2017012922697N2
Enrollment
40
Registered
2017-05-01
Start date
2017-04-04
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: pain after orthosurgery. Condition 2: nausea and vomiting after orthosurgery. Condition 3: Jaw deformity. Pain in joint Vomiting associated with other psychological disturbances Dentofacial anomaly, unspecified

Interventions

Intervention 1: Intervention 1:Prescription of ondansetron (8 mg) (150 µg) in form of oral tablets that have been dissolved in 20 ml of water (as intervention) one hour before general anesthesia of or
Treatment - Drugs
Intervention 1:Prescription of ondansetron (8 mg) (150 µg) in form of oral tablets that have been dissolved in 20 ml of water (as intervention) one hour before general anesthesia of orthosurgery
Intervention 2:Prescription of clonidine (150 µg) in form of oral tablets that have been dissolved in 20 ml of water (as intervention) one hour before general anesthesia of orthosurgery

Sponsors

Vice chancellor for research Mashhad university of medical sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: All adult patients with ASA class I, II, age range between 18 and 40 years and BMI less than 30 kg per square meter, with jaw deformity and applicable for orthosurgery that referred to Mashhad dental school. Exclusion criteria: Patients with ASA III class and more. Patients with history of nausea in moving vehicles (Motion sickness) Patients who had experience of previous Ponv, nausea and vomiting in last 24 hours Patients with upper gastrointestinal disorders such as peptic ulcer disease, re flux, pyloric stenosis Patients with history of drug abuse and addiction Patients known to be sensitive to clonidine and ondansetron Patients with history of low blood pressure and bradycardia Patients who need to be care in ICU after surgery. Patients who not wish to continue participation in the program, for any reason.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Amount of pain. Timepoint: 1,3,6,12,24 hours after surgery. Method of measurement: VAS.;Nausea and vomiting amount after surgery. Timepoint: 1,3,6,12,24 hours after surgery. Method of measurement: yes or no / dose of rescue anti emetic drug.

Secondary

MeasureTime frame
Bradycardia. Timepoint: 1,3,6,12,24 hours after surgery. Method of measurement: clinical observation.;Blood pressure. Timepoint: 1,3,6,12,24 hours after surgery. Method of measurement: clinical observation.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Majid Eshghpour

oral and maxillofacial surgery department ,Mashhad dental school

eshghpourm@mums.ac.ir+98 51 3882 9501

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026